Amedisys (AMED) Tops Q2 EPS by 22c
Tweet
Share
E-mail
Get Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Net income attributable to Amedisys, Inc.: 11.44M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Financial Fact:
Net income attributable to Amedisys, Inc.: 11.44M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q2 EPS of $1.00, $0.22 better than the analyst estimate of $0.78. Revenue for the quarter came in at $411.6 million versus the consensus estimate of $403.62 million.
GUIDANCE:
Amedisys sees FY2018 EPS of $3.32-$3.41, versus the consensus of $3.10. Amedisys sees FY2018 revenue of $1.63-1.65 million, versus the consensus of $1.63 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Green Dot and CommerceOne shareholders approve acquisition deal
- Worthington Industries (WOR) Misses Q4 EPS by 9c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
